Occupe actuellement un poste chez Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Co-Founder, Chief Operating Officer | Apellis Pharmaceuticals Inc | 1 janvier 2016 - |
Chief Operating Officer | Apellis Pharmaceuticals Inc | 1 septembre 2009 - 1 janvier 2016 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails | |
---|---|---|---|---|---|---|---|---|
2025-01-30 | 2025-01-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
826
-0.1%
29,5224 386 USD |
826 -0.1% | 29,52 | 24 386 USD | |
2024-05-09 | 2024-05-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
100
-0.0%
44,034 403 USD |
100 -0.0% | 44,03 | 4 403 USD | |
2024-05-09 | 2024-05-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
22 472
-2.0%
42,85962 903 USD |
22 472 -2.0% | 42,85 | 962 903 USD | |
2024-05-09 | 2024-05-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
56 335
-4.7%
42,152 374 543 USD |
56 335 -4.7% | 42,15 | 2 374 543 USD | |
2024-04-09 | 2024-04-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
4 728
-0.4%
54,92259 639 USD |
4 728 -0.4% | 54,92 | 259 639 USD | |
2024-04-09 | 2024-04-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
64 379
-5.4%
54,123 483 966 USD |
64 379 -5.4% | 54,12 | 3 483 966 USD | |
2024-03-11 | 2024-03-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
100
-0.0%
63,356 335 USD |
100 -0.0% | 63,35 | 6 335 USD | |
2024-03-11 | 2024-03-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
26 257
-2.3%
62,691 646 041 USD |
26 257 -2.3% | 62,69 | 1 646 041 USD | |
2024-03-11 | 2024-03-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
42 750
-3.6%
61,882 645 173 USD |
42 750 -3.6% | 61,88 | 2 645 173 USD | |
2024-02-13 | 2024-02-12 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
1 148
-0.1%
67,7777 796 USD |
1 148 -0.1% | 67,77 | 77 796 USD | |
2024-01-31 | 2024-01-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
874
-0.1%
64,1456 057 USD |
874 -0.1% | 64,14 | 56 057 USD | |
2024-01-23 | 2024-01-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
3 913
-0.3%
65,00254 329 USD |
3 913 -0.3% | 65,00 | 254 329 USD | |
2024-01-17 | 2024-01-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
1 632
-0.1%
66,81109 032 USD |
1 632 -0.1% | 66,81 | 109 032 USD | |
2023-11-09 | 2023-11-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.1%
47,27567 240 USD |
12 000 -1.1% | 47,27 | 567 240 USD | |
2023-10-10 | 2023-10-09 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.1%
40,38484 560 USD |
12 000 -1.1% | 40,38 | 484 560 USD | |
2023-09-11 | 2023-09-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
12 000
-1.1%
42,87514 440 USD |
12 000 -1.1% | 42,87 | 514 440 USD | |
2023-08-09 | 2023-08-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.1%
23,66283 920 USD |
12 000 -1.1% | 23,66 | 283 920 USD | |
2023-07-11 | 2023-07-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.1%
84,551 014 600 USD |
12 000 -1.1% | 84,55 | 1 014 600 USD | |
2023-06-09 | 2023-06-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.1%
91,351 096 200 USD |
12 000 -1.1% | 91,35 | 1 096 200 USD | |
2023-05-09 | 2023-05-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.1%
92,391 108 680 USD |
12 000 -1.1% | 92,39 | 1 108 680 USD | |
2023-04-11 | 2023-04-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.2%
78,21938 520 USD |
12 000 -1.2% | 78,21 | 938 520 USD | |
2023-03-10 | 2023-03-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.2%
63,79765 480 USD |
12 000 -1.2% | 63,79 | 765 480 USD | |
2023-02-10 | 2023-02-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.2%
54,45653 400 USD |
12 000 -1.2% | 54,45 | 653 400 USD | |
2023-01-10 | 2023-01-09 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.2%
46,08552 960 USD |
12 000 -1.2% | 46,08 | 552 960 USD | |
2022-12-12 | 2022-12-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.2%
47,50570 000 USD |
12 000 -1.2% | 47,50 | 570 000 USD | |
2022-11-10 | 2022-11-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.2%
46,47557 640 USD |
12 000 -1.2% | 46,47 | 557 640 USD | |
2022-10-11 | 2022-10-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.2%
57,50690 000 USD |
12 000 -1.2% | 57,50 | 690 000 USD | |
2022-09-12 | 2022-09-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.2%
63,98767 760 USD |
12 000 -1.2% | 63,98 | 767 760 USD | |
2022-08-09 | 2022-08-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.3%
62,50750 000 USD |
12 000 -1.3% | 62,50 | 750 000 USD | |
2022-07-12 | 2022-07-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.3%
47,95575 400 USD |
12 000 -1.3% | 47,95 | 575 400 USD | |
2022-06-09 | 2022-06-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 000
-1.3%
44,09529 080 USD |
12 000 -1.3% | 44,09 | 529 080 USD | |
2022-05-02 | 2022-04-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
4 000
-0.4%
44,43177 720 USD |
4 000 -0.4% | 44,43 | 177 720 USD | |
2021-06-25 | 2021-06-24 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
6 250
-0.7%
65,61410 063 USD |
6 250 -0.7% | 65,61 | 410 063 USD | |
2021-05-25 | 2021-05-24 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
6 250
-0.7%
47,40296 250 USD |
6 250 -0.7% | 47,40 | 296 250 USD | |
2021-04-26 | 2021-04-23 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
6 250
-0.7%
46,13288 313 USD |
6 250 -0.7% | 46,13 | 288 313 USD | |
2021-03-11 | 2021-03-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
6 250
-0.7%
50,74317 125 USD |
6 250 -0.7% | 50,74 | 317 125 USD | |
2020-02-14 | 2020-02-13 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
55 398
-5.2%
40,982 270 155 USD |
55 398 -5.2% | 40,98 | 2 270 155 USD | |
2020-02-14 | 2020-02-12 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
52 075
-5.2%
42,802 228 966 USD |
52 075 -5.2% | 42,80 | 2 228 966 USD | |
2019-09-26 | 2019-09-25 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
1 010
-0.1%
25,6425 897 USD |
1 010 -0.1% | 25,64 | 25 897 USD | |
2019-09-26 | 2019-09-25 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
20 531
-2.3%
25,24518 161 USD |
20 531 -2.3% | 25,24 | 518 161 USD | |
2019-09-25 | 2019-09-24 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
1 295
-0.1%
24,9632 321 USD |
1 295 -0.1% | 24,96 | 32 321 USD | |
2019-09-25 | 2019-09-24 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
20 307
-2.2%
24,56498 760 USD |
20 307 -2.2% | 24,56 | 498 760 USD | |
2019-09-25 | 2019-09-23 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
100
-0.0%
25,532 553 USD |
100 -0.0% | 25,53 | 2 553 USD | |
2019-09-25 | 2019-09-23 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
20 758
-2.2%
25,07520 362 USD |
20 758 -2.2% | 25,07 | 520 362 USD |
// ... existing code ... // ... rest of the file ...